Skip to main content
. Author manuscript; available in PMC: 2011 Jun 20.
Published in final edited form as: Clin Gastroenterol Hepatol. 2006 Dec 6;5(1):49–58. doi: 10.1016/j.cgh.2006.09.015

Table 3.

Univariate Analysis of Relationship Between H pylori Typing and Clinical Outcomes

Western countries (n = 244)
East Asia (n = 266)
Gastritis
n = 98
DU
n = 97
Cancer
n = 49
Gastritis
n = 86
DU
n = 90
Cancer
n = 90
BabA-H 75 (77%) 85 (88%) 41 (84%) 81 (94%) 80 (89%) 78 (93%)
BabA-L 4 (4.1%) 9 (9.3%) 6 (12%) 5 (5.8%) 10 (11%) 12 (13%)
BabA negative 19 (19%) 3 (3.1%)a 2 (4.1%)b 0 0 0
cagA positive 77 (79%) 85 (88%) 43 (88%) 82 (95%) 90 (100%) 88 (98%)
vacA s1 76 (78%) 88 (91%)b 43 (88%) 86 (100%) 90 (100%) 90 (100%)
cagA positive, s1, BabA-H 72 (73%) 76 (78%) 37 (76%) 77 (90%) 80 (89%) 76 (84%)
cagA positive, s1, BabA-L 3 (3.1%) 8 (8.2%) 4 (8.2%) 5 (5.8%) 10 (11%) 12 (13%)
cagA negative, s2, BabA negative 18 (18%) 3 (3.1%)c 2 (4.1%)b 0 0 0
Other types 5 (5.1%) 10 (10%) 6 (12%) 4 (4.7%) 0 2 (2.2%)

NOTE. Six samples from Western countries and 4 from East Asia had borderline results for BabA and were excluded. The P value was determined by the χ2 test.

a

P < .001 compared with gastritis.

b

P < .05 compared with gastritis.

c

P < .01 compared with gastritis.